Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2799261 | Diabetes Research and Clinical Practice | 2006 | 6 Pages |
Abstract
We identified two missense mutations, Ala40Thr (GCG â ACG) and Arg213Gly (CGG â GGG), and a silent mutation, Leu53Leu (CTG â TTG). For one of these variants, the Ala40Thr polymorphism, the frequency of Thr allele and the number of subjects with Thr allele (Ala/Thr + Thr/Thr) were higher in type 2 diabetic patients (n = 205) than those in non-diabetic subjects (n = 220) (33.2% versus 24.1%, p = 0.003 and 55.6% versus 42.7%, p = 0.008, respectively). The patients with Thr allele also showed earlier age at diagnosis of diabetes (42.2 ± 7.8 years versus 44.4 ± 6.9 years, p = 0.037) and higher prevalence of hypertension (53.5% versus 38.5%, p = 0.032) than those without the allele. Insulin sensitivity, furthermore, was evaluated in 71 type 2 diabetic patients with short insulin tolerance test (SITT). The patients with Thr allele showed lower insulin sensitivity (Kitt value of SITT) than those without the allele (1.78 ± 0.78%/min versus 2.33 ± 1.02%/min, p = 0.012), although no significant differences in other clinical and biochemical characteristics were observed between two groups. These results suggest that the genetic variant of EC-SOD gene is associated with insulin resistance and the susceptibility to type 2 diabetes.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Masanori Tamai, Hiroto Furuta, Hiromichi Kawashima, Asako Doi, Tohru Hamanishi, Hiroko Shimomura, Setsuya Sakagashira, Masahiro Nishi, Hideyuki Sasaki, Tokio Sanke, Kishio Nanjo,